A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: A randomized feasibility and safety study

  • Lipšic E
  • Van Der Meer P
  • Voors A
 et al. 
  • 30


    Mendeley users who have this article in their library.
  • 161


    Citations of this article.


Besides stimulating hematopoiesis, erythropoietin (EPO) protects against experimental ischemic injury in the heart. The present study evaluated the safety and tolerability of EPO treatment in non-anemic patients with acute myocardial infarction (MI).

Author-supplied keywords

  • Acute myocardial infarction
  • Endothelial progenitor cells
  • Erythropoietin

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free